Pathway to pharmacist medical provider status in Washington State
- PMID: 27836482
- DOI: 10.1016/j.japh.2016.09.003
Pathway to pharmacist medical provider status in Washington State
Abstract
Objectives: To describe Washington State's successful legal and legislative efforts to gain pharmacist medical provider status and major medical compensation and to compare those efforts with similar efforts in other states to identify key lessons learned.
Summary: Washington State Engrossed Substitute Senate Bill 5557 was enacted in 2015, securing pharmacists as medical providers and requiring compensation under major medical insurance for pharmacists providing health services (Revised Code of Washington 48.43.715). Other states have passed, or attempted to pass, pharmacist provider status bills, but none have achieved both pharmacist medical provider status and mandatory major medical compensation.
Conclusion: Pharmacist medical provider status ideally should include recognition as a medical provider and compensation through major medical health insurance as a clinical decision maker rather than an "incident-to" provider. Both elements should be sought as part of a complete legislative package to ensure sustainable patient access to needed health care services.
Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Pharmacist provider status legislation: Projections and prospects.J Am Pharm Assoc (2003). 2015 Mar-Apr;55(2):203-7. doi: 10.1331/JAPhA.2015.14176. J Am Pharm Assoc (2003). 2015. PMID: 25749265
-
Vaccination payments in states with provider status for pharmacists: A claims analysis.J Am Pharm Assoc (2003). 2025 Jan-Feb;65(1):102301. doi: 10.1016/j.japh.2024.102301. Epub 2024 Nov 23. J Am Pharm Assoc (2003). 2025. PMID: 39581347
-
Basic terminology in obtaining reimbursement for pharmacists' cognitive services.Am J Health Syst Pharm. 2007 Jan 15;64(2):186-92. doi: 10.2146/ajhp060234. Am J Health Syst Pharm. 2007. PMID: 17215470
-
Reimbursement for pharmacist-provided health care services: A multistate review.J Am Pharm Assoc (2003). 2021 Jan-Feb;61(1):27-32. doi: 10.1016/j.japh.2020.09.009. Epub 2020 Oct 15. J Am Pharm Assoc (2003). 2021. PMID: 33069593 Review.
-
Remunerated patient care services and injections by pharmacists: An international update.J Am Pharm Assoc (2003). 2019 Jan-Feb;59(1):89-107. doi: 10.1016/j.japh.2018.07.002. Epub 2018 Sep 6. J Am Pharm Assoc (2003). 2019. PMID: 30195440
Cited by
-
Sustaining Ambulatory Comprehensive Medication Management Practices: Perspectives from a Minnesota Pharmacist Collaborative.J Manag Care Spec Pharm. 2018 Dec;24(12):1264-1268. doi: 10.18553/jmcp.2018.24.12.1264. J Manag Care Spec Pharm. 2018. PMID: 30479198 Free PMC article.
-
Pharmacy deserts and COVID-19 risk at the census tract level in the State of Washington.Vaccine X. 2022 Oct 17;12:100227. doi: 10.1016/j.jvacx.2022.100227. eCollection 2022 Dec. Vaccine X. 2022. PMID: 36275889 Free PMC article.
-
Stakeholder perceptions of community pharmacist population health management of people living with epilepsy.Epilepsy Behav. 2021 Dec;125:108389. doi: 10.1016/j.yebeh.2021.108389. Epub 2021 Nov 11. Epilepsy Behav. 2021. PMID: 34775244 Free PMC article.
-
The Impact of Pharmacist-Based Services Across the Spectrum of Outpatient Heart Failure Therapy.Curr Treat Options Cardiovasc Med. 2019 Sep 10;21(10):59. doi: 10.1007/s11936-019-0750-3. Curr Treat Options Cardiovasc Med. 2019. PMID: 31506885 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources